2011
DOI: 10.1039/c1lc20125e
|View full text |Cite
|
Sign up to set email alerts
|

Disposable microfluidic substrates: Transitioning from the research laboratory into the clinic

Abstract: As more microfluidic applications emerge for clinical diagnostics, the choice of substrate and production method must be considered for eventual regulatory approval. In this review, we survey recent developments in disposable microfluidic substrates and their fabrication methods. We note regulatory approval for disposable microfluidic substrates will be more forthcoming if the substrates are developed with the United States Pharmacopeia's biocompatibility compliance guidelines in mind. We also review the recen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
57
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 71 publications
(57 citation statements)
references
References 150 publications
(152 reference statements)
0
57
0
Order By: Relevance
“…On the other extreme, techniques using paper and polyester-toner have been used to manufacture chips in less than 10 min with a cost lower than $ 0.10 per device, but the chemistry and topography of the materials often hinder the applicability of the technology [10,14,15]. Besides these examples, a range of polymers have emerged as alternative materials to fabricate ME devices [16][17][18][19]. In most cases, these plastics offer an adequate balance between fabrication procedures, cost, and analytical performance.…”
Section: Introductionmentioning
confidence: 99%
“…On the other extreme, techniques using paper and polyester-toner have been used to manufacture chips in less than 10 min with a cost lower than $ 0.10 per device, but the chemistry and topography of the materials often hinder the applicability of the technology [10,14,15]. Besides these examples, a range of polymers have emerged as alternative materials to fabricate ME devices [16][17][18][19]. In most cases, these plastics offer an adequate balance between fabrication procedures, cost, and analytical performance.…”
Section: Introductionmentioning
confidence: 99%
“…Finally, it should be noted that the use of regulatory-approved materials or modified regulatory-approved materials does not mean the device is regulatoryapproved, but that it may encounter less regulatory resistance. 8 …”
Section: A Cytotoxicitymentioning
confidence: 99%
“…9 Additionally, devices manufactured with regulatoryapproved materials may be more rapidly approved for use. 8 The commercial development of clinical microfluidic devices requires low-cost materials from regulatory-approved suppliers.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, the disposability of clinical diagnostic devices necessitates the use of plastics as the main substrate material to satisfy the practical requirements of a low production cost and mass producibility [6]. Therefore, several groups have explored a hybrid device approach, where soft materials such as elastomers are implemented into rigid plastic materials to fabricate microvalves or micropumps.…”
Section: Introductionmentioning
confidence: 99%